Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

, ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

08:20
10/12/19
10/12
08:20
10/12/19
08:20

J&J, Pentair among stocks with sage, growing dividends, Barron's says

Investors seeking yield at a time of potentially negative interest rates can find some refuge in dividend-paying stocks, Lawrence Strauss writes in this week's edition of Barron's. Illinois Tool Works (ITW), Johnson & Johnson (JNJ), Nucor (NUE), Pentair (PNR), and W.W. Grainger (GWW) have all increased their dividend for at least 25 straight years and their changes of more increases look solid, the author contends. Reference Link

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

JNJ Johnson & Johnson
$131.35

2.32 (1.80%)

10/02/19
WELS
10/02/19
NO CHANGE
WELS
Outperform
J&J Ohio settlements suggest 'manageable' liability, says Wells Fargo
Wells Fargo analyst Larry Biegelsen notes that Johnson & Johnson has announced a settlement agreement with the Ohio counties of Cuyahoga and Summit that resolves all of the counties' claims with no admission of liability and removes the company from the federal trial scheduled to begin October 21, 2019 for a total of $20.4M. The analyst notes that after applying the total settlement amount to the populations of Cuyahoga and Summit counties and that to the total U.S. population of 327M, he arrives at a total settlement amount of $3.7B, which is well below his expected total settlement amount of $10B-$15B. Importantly, Biegelsen expects any settlement amount to be paid over a period of many years which will make the potential payments more manageable for Johnson & Johnson. He has an Outperform rating on the shares.
10/11/19
BERN
10/11/19
UPGRADE
BERN
Outperform
Johnson & Johnson upgraded to Outperform from Market Perform at Bernstein
08/27/19
FBCO
08/27/19
NO CHANGE
Target $156
FBCO
Outperform
Opioid ruling reduces uncertainty, helps J&J move higher, says Credit Suisse
Credit Suisse analyst Matt Miksic notes that Johnson & Johnson appeared to react favorably to Oklahoma opioid ruling, due in part, to the $572M penalty being substantially lower than the $17B sought by State prosecutors. The analyst believes the decision helped reduce the range of uncertainty related to the potential opioid-related liability Johnson & Johnson could face, specifically in Oklahoma, if not across the U.S. more broadly. Miksic reiterates an Outperform rating and $156 target on the shares.
10/11/19
BERN
10/11/19
UPGRADE
Target $155
BERN
Outperform
Bernstein upgrades 'historically cheap' Johnson & Johnson to Outperform
Bernstein analyst Lee Hambright upgraded Johnson & Johnson to Outperform from Market Perform with a price target of $155, up from $148. The shares in premarket trading are up $1.94, or 1.5%, to $131. The stock is "historically cheap," currently trading at a 17% discount to its sum-of-the-parts and a 13% discount to the S&P 500 Index, Hambright tells investors in a research note. The analyst, who believes J&J will resolve its legal liability for $10B-$12B, says the shares reflect a worst case scenario with $50B of liabilities being priced in. Following discussions with legal experts, Hambright has a "hard time seeing the worst-case scenarios playing out." The analyst estimates Johnson & Johnson faces about $5B of liability for opioids, another $5B for talc, and $800M for Risperdal.
ITW Illinois Tool Works
$154.56

4.68 (3.12%)

07/10/19
DBAB
07/10/19
NO CHANGE
DBAB
Deutsche says buy Stanley, sell Illinois Tool Works and Parker-Hannifin into Q2
Deutsche Bank analyst Nicole DeBlase placed a "Catalyst Call" buy on Stanley Black & Decker (SWK) along with "Catalyst Call" sells on both Illinois Tool Works (ITW) and Parker-Hannifin (PH) into the Q2 reporting season. She believes expectations are low for Stanley going into the print but sees downside to estimates for Illinois Tool Works and Parker-Hannifin.
07/29/19
FBCO
07/29/19
NO CHANGE
Target $152
FBCO
Neutral
Illinois Tool Works price target raised to $152 from $124 at Credit Suisse
Credit Suisse analyst Jamie Cook raised his price target for Illinois Tool Works to $152 from $124 despite the company missing EPS estimates for the quarter and lowering the full-year guide for organic growth given a deceleration of demand across the portfolio. The analyst notes that Illinois Tool Works continues to post "strong decremental margins," and looks to see how it will perform in the back half of the year given identified tailwinds versus the first half. Cook reiterates a Neutral rating on the shares.
09/23/19
GSCO
09/23/19
DOWNGRADE
Target $144
GSCO
Sell
Illinois Tool Works downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Joe Ritchie downgraded Illinois Tool Works (ITW) to Sell from Neutral and lowered his price target for the shares to $144 from $147. Given the company's "deteriorating fundamentals," there is downside risk to consensus estimates and its valuation premium relative to Large Cap Defensive peers "appears too high," Ritchie tells investors in a research note. The analyst believes growth in all of Illinois Tool Works' segments could turn negative in Q4 while the return to greater than 2% growth in 2020 "could prove optimistic." Further, after years of transforming the cost structure and driving meaningful margin expansion, the company "has less levers to pull to expand margins," says Ritchie. The analyst continues to view Honeywell (HON) as the best Large Cap Defensive to own.
06/26/19
06/26/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. State Street (STT) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying he has "very little confidence" in when the company will be able to get past the headwinds it is facing. 2. Allergan (AGN) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying she views the AbbVie (ABBV) deal as "a hard-fought and timely exit" for shareholders, citing her concerns about the weakness in Allergan's aesthetics portfolio and the company's growth challenges. 3. Kinder Morgan (KMI) downgraded to Market Perform from Outperform at Raymond James with analyst Justin Jenkins saying shares are up approximately 35% year-to-date and trade at an above-peer multiple despite a mixed outlook for the asset portfolio. 4. Papa John's (PZZA) downgraded to Neutral from Buy at Kalinowski. 5. Illinois Tool Works (ITW) downgraded to Sell from Neutral at Northcoast with the firm's analyst citing concentrated Automotive exposure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NUE Nucor
$52.69

2.48 (4.94%)

06/26/19
JEFF
06/26/19
NO CHANGE
JEFF
Nucor flat rolled price increase likely to help sentiment, says Jefferies
After Nucor (NUE) announced a $40/t flat rolled price increase yesterday, which was the first increase since February, Jefferies analyst Martin Englert said he thinks peers are likely to follow. While the increase may not immediately raise prices, it is a move in the right direction that aids more positive sector sentiment, Englert tell investors. The analyst, who advises investors to increase exposure to steel stocks, names Nucor, Steel Dynamics (STLD), Cleveland-Cliffs (CLF) and Commercial Metals (CMC) as his top U.S. picks Other publicly traded companies in the steel space include AK Steel (AKS), ArcelorMittal (MT), TimkenSteel (TMST) and U.S. Steel (X).
09/23/19
JPMS
09/23/19
DOWNGRADE
JPMS
Underweight
JPMorgan double downgrades AK Steel, cuts U.S. Steel on flattish price outlook
JPMorgan analyst Michael Gambardella earlier today lowered his estimates and price targets for the steel companies to reflect a "more flattish" steel price environment. The analyst also double downgraded AK Steel (AKS) to Underweight from Overweight and downgraded U.S. Steel (X) to Neutral Overweight. He removed U.S. Steel from his firm's Analyst Focus List. The U.S. steel stocks and steel prices have been under pressure this year, which is largely due to concerns about supply additions planned for the next several years, continued uncertainty surrounding trade, and some softening in demand, Gambardella tells investors in a research note. Further, after a brief rebound, steel and scrap prices are now heading lower, adds the analyst. He kept Overweight ratings on Commercial Metals (CMC), Nucor (NUE), Steel Dynamics (STLD), and Stelco Holdings (STZHF).
05/31/19
05/31/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mallinckrodt (MNK) downgraded to Neutral from Overweight at Piper Jaffray with analyst David Amsellem stating last week's developments regarding Acthar in the Medicaid setting, along with as much as a $600M Centers for Medicare & Medicaid Services-related liability, "essentially blew" his prior investment thesis to "smithereens." 2. Nucor (NUE) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners incorporating a lower near-term forecast for prices, especially for sheet and rebar, and a lower 2021-2022 forecast given expectations for a looming glut in steel. 3. J.Jill (JILL) downgraded to Hold from Buy at Deutsche Bank with analyst Lorraine Hutchinson stating that she expects the stock's multiple to contract due to the company's slower growth. 4. Nutanix (NTNX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Andrew Nowinski citing the company's "continued execution issues," which he attributes partially to increasing competition. 5. Zuora (ZUO) downgraded to Buy from Strong Buy at Needham with analyst Scott Berg saying that the stock could be "dead money" for the next 1-2 quarters, noting that the sales issues are more concerning than the product issues and may require a change in sales leadership. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/31/19
BOFA
05/31/19
DOWNGRADE
Target $50
BOFA
Underperform
Nucor downgraded to Underperform from Buy at BofA/Merrill
BofA Merrill Lynch analyst Timna Tanners double downgraded Nucor, to Underperform from Buy, to incorporate a lower near-term forecast for prices, especially for sheet and rebar, and a lower 2021-2022 forecast given expectations for a looming glut in steel. Nucor produces three of the products that Tanners thinks will be most hurt by new supply: sheet, rebar, and plate. The analyst lowered the price target on Nucor shares to $50 from $68.
PNR Pentair
$37.33

1.215 (3.36%)

04/10/19
BMOC
04/10/19
NO CHANGE
Target $43
BMOC
Market Perform
Pentair price target lowered to $43 from $47 at BMO Capital
BMO Capital analyst R. Scott Graham lowered his price target on Pentair to $43 after the company cut its Q1 and 2019 guidance due to weather factors impacting its high-margin Aquatics segment, channel inventory excesses, and slowdown in other verticals. The analyst also keeps his Market Perform rating but maintains a positive view on the company's portfolio, margins, and free cash flow profiles, stating that the stock price decline after yesterday's guidance may be overdone.
04/18/19
BMOC
04/18/19
NO CHANGE
Target $39
BMOC
Pentair price target lowered to $39 from $43 at BMO Capital
BMO Capital analyst R. Scott Graham lowered his price target on Pentair to $39 and kept his Market Perform rating after its Q1 earnings miss and below-consensus outlook for Q2. The analyst notes that the company's Aquatic and Flow segments were impacted by the poor weather in Q1 as discussed in its negative pre-announcement, but the latest results also indicated weakness in its Filtration sales. Graham maintains his view that Pentair's prior organic sales guidance is "aggressive", lowering his expected FY19 and FY20 EPS outlook again by 5c and 8c to $2.25 and $2.45 respectively.
04/22/19
COWN
04/22/19
NO CHANGE
Target $45
COWN
Outperform
Pentair price target lowered to $45 from $52 at Cowen
Cowen analyst Joseph Giordano lowered his price target on Pentair to $45 from $52, saying a 20% down move after a 10% guidance cut largely driven by weather and related inventory was "disappointing and likely excessive." True momentum will take time now, but the setup into 2020 will likely be attractive with beatable comps, low expectations, and a discounted multiple, Giordano tells investors in a research note. He maintains an Outperform rating.
09/20/19
JEFF
09/20/19
INITIATION
Target $40
JEFF
Hold
Pentair initiated with a Hold at Jefferies
Jefferies analyst Saree Boroditsky initiated Pentair with a Hold rating and $40 price target, stating that while she is positive on the company's long-term outlook, she sees risk to 2019 earnings given headwinds in Aquatics and tough comparisons for Q4. However, she thinks these headwinds become tailwinds next year, leaving the unique pure-play water franchise set up for a more positive 2020.
GWW Grainger
$305.24

16.49 (5.71%)

06/21/19
06/21/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Carnival (CCL) downgraded to Equal Weight from Overweight at Barclays with analyst Felicia Hendrix saying the company's challenges in Europe, which could continue into next year, make it difficult to justify the sane Overweight rating that is on peers Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH). 2. Caterpillar (CAT) downgraded to Underweight from Neutral at Atlantic Equities. 3. Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities. 4. AnaptysBio (ANAB) downgraded to Neutral from Outperform at Credit Suisse and to Hold from Buy at Stifel. 5. Sealed Air (SEE) downgraded to Neutral from Buy at BofA/Merrill with analyst George Staphos citing the company's announcement that its board terminated William Stiehl as Chief Financial Officer for cause relating to the process by which the company selected its independent audit firm. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/21/19
ATLE
06/21/19
DOWNGRADE
Target $260
ATLE
Underweight
Grainger downgraded to Underweight from Neutral at Atlantic Equities
Atlantic Equities analyst Richard Radbourne downgraded Grainger to Underweight from Neutral and lowered his price target for the shares to $260 from $315.
05/17/19
GDHS
05/17/19
UPGRADE
GDHS
Hold
Grainger upgraded to Hold from Reduce at Gordon Haskett
Gordon Haskett analyst John Inch upgraded Grainger to Hold from Reduce saying EPG could provide near term stabilization.
04/23/19
BMOC
04/23/19
NO CHANGE
Target $310
BMOC
Market Perform
Grainger price target lowered to $310 from $320 at BMO Capital
BMO Capital analyst R. Scott Graham lowered his price target on Grainger to $310 and kept his Market Perform rating, saying that while the company beat on Q1 earnings and affirmed FY19 guidance, the tone of the conference call was more "supportive of midpoint" of FY19 outlook and "perhaps a bit lower". The analyst cites slowing U.S. sales, potential peaking in pricing, and his expected flat operating margins for the rest of 2019. Graham also points to "poor" results from Grainger's Canada business and his expectations of business spending remaining "accelerated".

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/14/19
10/14
12:17
10/14/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/14/19
10/14
12:16
10/14/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HGV

Hilton Grand Vacations

$32.59

-0.09 (-0.28%)

12:12
10/14/19
10/14
12:12
10/14/19
12:12
Hot Stocks
Breaking Hot Stocks news story on Hilton Grand Vacations »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HGV

Hilton Grand Vacations

$32.59

-0.09 (-0.28%)

, APO

Apollo Global

$38.61

-0.11 (-0.28%)

12:11
10/14/19
10/14
12:11
10/14/19
12:11
Hot Stocks
Hilton Grand Vacations jumps after Apollo Global said to bid $40 per share »

Shares of Hilton Grand…

HGV

Hilton Grand Vacations

$32.59

-0.09 (-0.28%)

APO

Apollo Global

$38.61

-0.11 (-0.28%)

BX

Blackstone

$46.23

-0.87 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 07

    Nov

DB

Deutsche Bank

$7.57

0.1 (1.34%)

12:10
10/14/19
10/14
12:10
10/14/19
12:10
Periodicals
Deutsche Bank lavished gifts in China to win business, NY Times reports »

In a campaign to win…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

HGV

Hilton Grand Vacations

$32.60

-0.08 (-0.24%)

, APO

Apollo Global

$38.60

-0.12 (-0.31%)

12:08
10/14/19
10/14
12:08
10/14/19
12:08
Periodicals
Breaking Periodicals news story on Hilton Grand Vacations, Apollo Global »

Apollo said to bid near…

HGV

Hilton Grand Vacations

$32.60

-0.08 (-0.24%)

APO

Apollo Global

$38.60

-0.12 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 07

    Nov

HGV

Hilton Grand Vacations

$32.60

-0.08 (-0.24%)

12:06
10/14/19
10/14
12:06
10/14/19
12:06
Hot Stocks
Breaking Hot Stocks news story on Hilton Grand Vacations »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$42.08

-0.69 (-1.61%)

12:05
10/14/19
10/14
12:05
10/14/19
12:05
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Large Cap Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

GGAL

Grupo Financiero

$12.99

-0.06 (-0.46%)

12:05
10/14/19
10/14
12:05
10/14/19
12:05
Options
Grupo Financiero call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
10/14/19
10/14
11:55
10/14/19
11:55
Conference/Events
JPMorgan telecom/networking equip analyst holds analyst/industry conference call »

Telecom & Networking…

VST

Vistra Energy

$27.00

-0.08 (-0.30%)

11:55
10/14/19
10/14
11:55
10/14/19
11:55
Options
Vistra Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDC

SmileDirectClub

$10.11

-0.99 (-8.92%)

11:50
10/14/19
10/14
11:50
10/14/19
11:50
On The Fly
SmileDirectClub drops after Dental Board of California sunset bill signed »

Shares of SmileDirectClub…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RVNC

Revance

$13.01

0.84 (6.90%)

11:47
10/14/19
10/14
11:47
10/14/19
11:47
Recommendations
Revance analyst commentary  »

Stifel surprised by CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

HAL

Halliburton

$18.43

-0.515 (-2.72%)

11:45
10/14/19
10/14
11:45
10/14/19
11:45
Options
Halliburton call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

NKE

Nike

$94.87

0.97 (1.03%)

, WDC

Western Digital

$59.11

0.75 (1.29%)

11:41
10/14/19
10/14
11:41
10/14/19
11:41
On The Fly
Nike, Western Digital upgrades among today's top analyst calls »

Check out today's top…

NKE

Nike

$94.87

0.97 (1.03%)

WDC

Western Digital

$59.11

0.75 (1.29%)

TPR

Tapestry

$24.94

-1.03 (-3.97%)

HPE

HP Enterprise

$14.77

0.42 (2.93%)

XLNX

Xilinx

$96.33

0.15 (0.16%)

DAL

Delta Air Lines

$52.71

-0.23 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

SDC

SmileDirectClub

$10.33

-0.77 (-6.94%)

11:32
10/14/19
10/14
11:32
10/14/19
11:32
Recommendations
SmileDirectClub analyst commentary  »

SmileDirectClub may have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

INTC

Intel

$51.65

-0.41 (-0.79%)

11:28
10/14/19
10/14
11:28
10/14/19
11:28
Periodicals
Intel may skip 10nm for desktop CPUs, Wccftech reports »

Intel is planning to skip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 20

    Nov

BKNG

Booking Holdings

$1,985.99

11.08 (0.56%)

, FB

Facebook

$183.97

-0.23 (-0.12%)

11:25
10/14/19
10/14
11:25
10/14/19
11:25
Periodicals
Booking Holdings no longer supporting Facebook's Libra cryptocurrency, CNBC says »

CNBC Now tweeted…

BKNG

Booking Holdings

$1,985.99

11.08 (0.56%)

FB

Facebook

$183.97

-0.23 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 30

    Oct

M

Macy's

$15.17

-0.56 (-3.56%)

11:25
10/14/19
10/14
11:25
10/14/19
11:25
Options
Macy's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CARA

Cara Therapeutics

$19.13

0.29 (1.54%)

11:22
10/14/19
10/14
11:22
10/14/19
11:22
Recommendations
Cara Therapeutics analyst commentary  »

Stifel still optimistic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZUL

Azul

$37.10

0.25 (0.68%)

, UAL

United Airlines

$86.50

-0.68 (-0.78%)

11:20
10/14/19
10/14
11:20
10/14/19
11:20
Periodicals
Azul in talks to join United, Copa, Avianca partnership, Reuters reports »

Brazilian airline Azul…

AZUL

Azul

$37.10

0.25 (0.68%)

UAL

United Airlines

$86.50

-0.68 (-0.78%)

CPA

Copa Holdings

$98.68

-0.67 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/14/19
10/14
11:17
10/14/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/14/19
10/14
11:16
10/14/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEM

Kemet

$20.96

0.305 (1.48%)

11:15
10/14/19
10/14
11:15
10/14/19
11:15
Options
Kemet put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$24.59

0.26 (1.07%)

11:05
10/14/19
10/14
11:05
10/14/19
11:05
Options
Intelsat call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.